Christine M. Hunt

Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

Ching‐Lung Lai, Jules L. Dienstag, Eugene R. Schiff et al. · Clinical Infectious Diseases · 2003 · 637 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Effect of age and gender on the activity of human hepatic CYP3A

Christine M. Hunt, William R. Westerkam, Gregg M. Stave · Biochemical Pharmacology · 1992 · 428 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™

Ayako Suzuki, Raúl J. Andrade, Einar S. Björnsson et al. · Drug Safety · 2010 · 169 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial

Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Sanjiv Chopra et al. · Hepatology · 2000 · 164 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Effect of Interferon-α Treatment of Chronic Hepatitis C on Health-Related Quality of Life

Christine M. Hunt, Jason A. Dominitz, Barbara Philips Bute et al. · Digestive Diseases and Sciences · 1997 · 145 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14